[
  {
    "date": "2023-03-30",
    "symbol": "NMRD",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-03-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--03-31",
    "entityfilenumber": "001-38355",
    "entityregistrantname": "NEMAURA MEDICAL INC.",
    "entitycentralindexkey": 1602078,
    "entitytaxidentificationnumber": "46-5027260",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "57 West 57th Street",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10019,
    "cityareacode": 646,
    "localphonenumber": "416-8000",
    "security12btitle": "Common Stock",
    "tradingsymbol": "NMRD",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entitypublicfloat": 25200000,
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 572,
    "auditorname": "Weinberg & Company, P.A.",
    "auditorlocation": "Los Angeles, California",
    "cashandcashequivalentsatcarryingvalue": 10105135,
    "inventorynet": 1754852,
    "prepaidexpenseandotherassetscurrent": 357934,
    "valueaddedtaxreceivablecurrent": 409648,
    "depositonforeignexchangecontract": 909666,
    "assetscurrent": 13537235,
    "propertyplantandequipmentnet": 641906,
    "finitelivedintangibleassetsnet": 384092,
    "assets": 14563233,
    "accountspayablecurrent": 326641,
    "accruedliabilitiesandotherliabilities": 130678,
    "notespayablecurrent": 16942500,
    "payabletorelatedparties": 920780,
    "deferredrevenuecurrent": 123640,
    "foreignexchangecontractderivativeliability": 731730,
    "warrantliability": 3092000,
    "liabilitiescurrent": 22267969,
    "longtermnotespayable": 3087651,
    "deferredrevenueandcreditsnoncurrent": 1021811,
    "liabilities": 26377431,
    "commonstockvalue": 28899,
    "additionalpaidincapitalcommonstock": 40991377,
    "retainedearningsaccumulateddeficit": -51875211,
    "accumulatedothercomprehensiveincomelossnetoftax": -959263,
    "stockholdersequity": -11814198,
    "liabilitiesandstockholdersequity": 14563233,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 42000000,
    "commonstocksharesissued": 28899402,
    "commonstocksharesoutstanding": 28899402,
    "revenues": 77044,
    "costofgoodsandservicessold": 75328,
    "costofsalesinventorywritedown": 1478108,
    "grossprofit": -1476392,
    "researchanddevelopmentexpense": 1538615,
    "generalandadministrativeexpense": 5600188,
    "assetimpairmentcharges": 980039,
    "operatingexpenses": 8118842,
    "operatingincomeloss": -9595234,
    "interestincomeexpensenet": -6412501,
    "changeinfairvalueofwarrantliability": 1864000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -14143735,
    "netincomeloss": -14143735,
    "translationadjustmentfunctionaltoreportingcurrencyincreasedecreasegrossoftax": -836946,
    "comprehensiveincomenetoftax": -14980681,
    "earningspersharebasic": -0.57,
    "earningspersharediluted": -0.57,
    "weightedaveragenumberofsharesoutstandingbasic": 24878196,
    "weightedaveragenumberofdilutedsharesoutstanding": 24878196,
    "sharesoutstanding": 28899402,
    "stockissuedduringperiodvalueother": 4796,
    "stockissuedduringperiodsharesother": 4796536,
    "fairvalueofwarrantliabilityrecognizedinconnectionwithissuanceofcommonsharesamount": -4956000,
    "othercomprehensiveincomeforeigncurrencytranslationgainlossarisingduringperiodtax": -836946,
    "profitloss": -14143735,
    "depreciationdepletionandamortization": 444177,
    "amortizationofdebtdiscountpremium": 1871593,
    "monitoringfeeinterestexpenseaddedtonotespayable": 2240339,
    "feesfornoteamendmentsexpenseaddedtonotepayable": 2304539,
    "inventorywritedown": 1478108,
    "impairmentofintangibleassetsexcludinggoodwill": 980039,
    "changeinfairvalueofforeignexchangecontract": 291534,
    "changesinfairvalueofwarrantliability": 1864000,
    "increasedecreaseininventories": 1745189,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 17415,
    "depositonforeignexchangecontracts": 909666,
    "increasedecreaseinaccountspayable": 190331,
    "increasedecreaseinaccountspayableandaccruedliabilities": -427748,
    "increasedecreaseinaccountsreceivablerelatedparties": -1022077,
    "increasedecreaseindeferredrevenue": -166765,
    "netcashprovidedbyusedinoperatingactivities": -8451781,
    "paymentstoacquirepropertyplantandequipment": 376170,
    "paymentstoacquireintangibleassets": 135168,
    "paymentstodevelopsoftware": 27879,
    "netcashprovidedbyusedininvestingactivities": -539217,
    "proceedsfromissuanceofcommonstock": 8394056,
    "costsincurredinrelationtoequityfinancing": 737658,
    "proceedsfromissuanceoflongtermdebt": 4700000,
    "repaymentsofnotespayable": 10274281,
    "netcashprovidedbyusedinfinancingactivities": 2082117,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -6908881,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -735217,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 10105135,
    "fairvalueofwarrantliabilityrecognizedinconnectionwithissuanceofcommonshares": 4956000,
    "monitoringfeesaddedtonotespayable": 2240339,
    "classofwarrantorrightoutstanding": 6369304,
    "foreigncurrencyexchangeratetranslation1": 1.236,
    "foreigncurrencyaverageexchangerates1": 1.215,
    "foreigncurrencycontractsliabilityfairvaluedisclosure": 731730,
    "warrantderivativeliabilityfairvalue": 3092000,
    "liabilitiesfairvaluedisclosure": 731730,
    "warrantderivativeliability": 3092000,
    "fairvalueofwarrantderivativeliabilityrecognizeduponissuanceofwarrants": 4956000,
    "gainonchangeinfairvalueofwarrantderivativeliability": 1864000,
    "capitalizedcomputersoftwaregross": 655641,
    "employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense": 37645,
    "valueaddedtaxreceivable": 255112,
    "advanceroyaltiescurrent": 1000000,
    "advanceroyalties": 1230000,
    "deferredrevenue": 1081676,
    "inventoryrawmaterials": 1586777,
    "inventoryfinishedgoods": 168075,
    "machineryandequipmentgross": 998635,
    "furnitureandfixturesgross": 114863,
    "propertyplantandequipmentgross": 1113498,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 471592,
    "depreciation": 156000,
    "finitelivedpatentsgross": 1175580,
    "finitelivedintangibleassetsaccumulatedamortization": 467091,
    "impairmentofintangibleassetsfinitelived": 324397,
    "finitelivedintangibleassetsgross": 384092,
    "intangibleassetsnetexcludinggoodwill": 384092,
    "amortizationofintangibleassets": 193000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y4M2D",
    "fairvalueadjustmentofwarrants": 3092000,
    "derivativeliabilitynotionalamount": 4250000,
    "fairvalueofcontractliabilityleveragedamounts": 8500000,
    "fairvalueofcontractliabilitiesexpectedremainingterm": "P17M",
    "debtinstrumentperiodicpayment": 2000000,
    "fairvalueofcontractliabilityleveragedamountsexpired": 4000000,
    "longtermdebt": 14772293,
    "debtinstrumentcarryingamount": 20797234,
    "debtinstrumentunamortizeddiscount": 767083,
    "longtermdebtcurrent": 16942500,
    "longtermdebtnoncurrent": 3087651,
    "debtinstrumentfairvalue": 17090513,
    "fairvalueoptionineligibleitemsaggregatecarryingamount": 16609176,
    "debtinstrumentcollateralfee": 2304539,
    "relatedpartytransactionduefromtorelatedparties": 920780,
    "amountsinvoicedbypharmatoddlnmandtclprimarilyrelatingtoresearchanddevelopmentexpenses": 4767586,
    "amountsrepaidbyddltopharma": 3773217,
    "foreigncurrencytranslationrelatedparty": 27708,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -13314440,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -829295,
    "incomelossattributabletoparent": -14143735,
    "lossbeforeincometaxes": -14143735,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3145943,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationforeignincometaxratedifferential": 235938,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.02,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 369946,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.03,
    "prioryeartrueupofnols": -46393,
    "incometaxreconciliationotheradjustments": 338278,
    "effectiveincometaxratereconciliationotheradjustments": 0.02,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2988066,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.21,
    "deferredtaxassetsoperatinglosscarryforwards": 9259000,
    "researchanddevelopmentenhancement": 361000,
    "otheritems": 38000,
    "deferredtaxassetsvaluationallowance": 9658000,
    "operatinglosscarryforwards": 11300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4796206,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P2Y8M12D",
    "shareprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.0228
  },
  {
    "date": "2022-03-30",
    "symbol": "NMRD",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2022-03-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--03-31",
    "entityfilenumber": "001-38355",
    "entityregistrantname": "NEMAURA MEDICAL INC.",
    "entitycentralindexkey": 1602078,
    "entitytaxidentificationnumber": "46-5027260",
    "entityincorporationstatecountrycode": "NV",
    "entityaddressaddressline1": "57 West 57th Street",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10019,
    "cityareacode": 646,
    "localphonenumber": "416-8000",
    "security12btitle": "Common Stock",
    "tradingsymbol": "NMRD",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "auditorname": "Mayer Hoffman McCann P.C",
    "auditorlocation": "Colorado",
    "auditorfirmid": 199,
    "cashandcashequivalentsatcarryingvalue": 17749233,
    "prepaidexpenseandotherassets": 750167,
    "accountsreceivablerelatedpartiescurrent": 101297,
    "inventorynet": 1487771,
    "assetscurrent": 20088468,
    "propertyplantandequipmentnet": 532508,
    "finitelivedintangibleassetsnet": 1480980,
    "otherassetsnoncurrent": 2013488,
    "assets": 22101956,
    "accountspayablecurrent": 136310,
    "otherliabilitiescurrent": 998622,
    "notespayablecurrent": 19188724,
    "deferredrevenuecurrent": 259256,
    "liabilitiescurrent": 20582912,
    "deferredrevenueandcreditsnoncurrent": 1052960,
    "liabilities": 21635872,
    "commonstockvalue": 24103,
    "additionalpaidincapitalcommonstock": 38295775,
    "retainedearningsaccumulateddeficit": -37731476,
    "accumulatedothercomprehensiveincomelossnetoftax": -122318,
    "stockholdersequity": 466084,
    "liabilitiesandstockholdersequity": 22101956,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 42000000,
    "commonstocksharesissued": 24102866,
    "commonstocksharesoutstanding": 24102866,
    "revenues": 503906,
    "costofgoodsandservicessold": 344300,
    "grossprofit": 159606,
    "researchanddevelopmentexpense": 1556988,
    "generalandadministrativeexpense": 6173049,
    "operatingexpenses": 7730037,
    "operatingincomeloss": -7570431,
    "interestincomeexpensenet": -6666630,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -14237061,
    "incometaxexpensebenefit": -350256,
    "netincomeloss": -13886805,
    "translationadjustmentfunctionaltoreportingcurrencyincreasedecreasegrossoftax": -257885,
    "comprehensiveincomenetoftax": -14144690,
    "netlosspersharebasicanddiluted": -0.59,
    "weightedaveragenumberofsharesoutstanding": 23383758,
    "sharesoutstanding": 24102866,
    "stockissuedduringperiodvaluenewissues": 773,
    "stockissuedduringperiodsharesnewissues": 772524,
    "exerciseofwarrantsamount": 367,
    "exerciseofwarrantsshares": 366892,
    "restrictedsharesissuedasstockbasedcompensationamount": 22,
    "restrictedsharesissuedasstockbasedcompensationshares": 22293,
    "stockissuedduringperiodvaluestockoptionsexercised": 133529,
    "othercomprehensiveincomeforeigncurrencytranslationgainlossarisingduringperiodtax": -257885,
    "issuanceofcommonsharesnetofcosts": 50765,
    "profitloss": -13886805,
    "depreciationdepletionandamortization": 229810,
    "accretionexpense": 6666630,
    "marktomarketforeignexchangerevaluation": 440196,
    "sharebasedcompensation": 220917,
    "increasedecreaseinprepaidexpensesother": -519346,
    "increasedecreaseininventories": 637149,
    "increasedecreaseinaccountspayable": -117384,
    "increasedecreaseinaccountsreceivablerelatedparties": 250092,
    "increasedecreaseinotheraccruedliabilities": 310490,
    "netcashprovidedbyusedinoperatingactivities": -6504041,
    "paymentstoacquireintangibleassets": 83691,
    "paymentstoacquirepropertyplantandequipment": 481718,
    "paymentstodevelopsoftware": 391073,
    "netcashprovidedbyusedininvestingactivities": -956482,
    "proceedsfromissuanceofcommonstock": 3118792,
    "costsincurredinrelationtoequityfinancing": 50765,
    "proceedsfromwarrantexercises": 2963658,
    "repaymentsofnotespayable": 12400000,
    "netcashprovidedbyusedinfinancingactivities": -6368315,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -13828838,
    "foreigncurrencytransactiongainlossrealized": -287300,
    "monitoringfeesaddedtonotespayable": 2764775,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.21,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1573098,
    "othercomprehensiveincomelosstax": 12500000,
    "employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense": 24300,
    "advanceroyalties": 1320000,
    "deferredrevenue": 107000,
    "propertyplantandequipmentgross": 806117,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 273609,
    "depreciation": 138000,
    "finitelivedpatentsgross": 1084081,
    "finitelivedintangibleassetsaccumulatedamortization": 186927,
    "finitelivedintangibleassetsgross": 897154,
    "capitalizedcomputersoftwarenet": 583826,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 174964,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 173910,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 173857,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 149783,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 98307,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 126333,
    "amortizationofintangibleassets": 92000,
    "prepaidexpensecurrent": 473799,
    "prepaidtaxes": 276368,
    "relatedpartytransactionduefromtorelatedparty": -101297,
    "amountinvoicedbypharmatoddlandtcl": 3245985,
    "amountsinvoicedbyddltopharma": -2495,
    "amountsrepaidbyddltopharma": -3492962,
    "foreigncurrencytranslationrelatedparty": -620,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -11716916,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -2520145,
    "incomelossattributabletoparent": -14237061,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -2989783,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationforeignincometaxratedifferential": 234338,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.02,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 463591,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.03,
    "prioryeartrueupofnols": 2401930,
    "incometaxreconciliationprioryeartrueupofnols": 0.17,
    "incometaxreconciliationotheradjustments": 74579,
    "effectiveincometaxratereconciliationotheradjustments": 0.01,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 742527,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.05,
    "rdcreditreceived": 350256,
    "incometaxreconciliationrdcreditreceived": 0.02,
    "currentincometaxexpensebenefit": 350256,
    "effectiveincometaxratecontinuingoperations": 0.02,
    "deferredtaxassetsoperatinglosscarryforwards": 6671000,
    "researchanddevelopmentenhancement": 335000,
    "otheritems": -335000,
    "deferredtaxassetsvaluationallowance": 6671000,
    "incometaxreconciliationtaxcreditsother": 350256,
    "deferredincometaxesandtaxcredits": 335832,
    "operatinglosscarryforwards": 8351000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 40000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P4Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 40000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P4Y9M29D",
    "shareprice": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 3.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.2252,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.0228,
    "saleofstockpricepershare": 4.07,
    "saleofstockconsiderationreceivedontransaction": 1600000,
    "proceedsfromissuanceofwarrants": 609118,
    "warrantsexercised": 58569,
    "classofwarrantorrightoutstanding": 135753,
    "allocatedsharebasedcompensationexpense": 50000,
    "stockcompensationexpensepaid": 59000
  },
  {
    "date": "2021-03-30",
    "symbol": "NMRD",
    "period": "FY",
    "entityregistrantname": "Nemaura Medical Inc.",
    "documenttype": "10-K",
    "documentperiodenddate": "2021-03-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1602078,
    "currentfiscalyearenddate": "--03-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-38355",
    "entityincorporationstatecountrycode": "NV",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 31865371,
    "prepaidexpenseandotherassets": 1269513,
    "inventorynet": 850622,
    "assetscurrent": 33985506,
    "propertyplantandequipmentnet": 202145,
    "finitelivedintangibleassetsnet": 1055256,
    "otherassetsnoncurrent": 1257401,
    "assets": 35242907,
    "accountspayablecurrent": 253694,
    "duetorelatedpartiescurrent": 148795,
    "otherliabilitiescurrent": 180552,
    "notespayablecurrent": 5733370,
    "deferredrevenuecurrent": 103470,
    "liabilitiescurrent": 6419881,
    "longtermnotespayable": 19188724,
    "deferredrevenueandcreditsnoncurrent": 1276130,
    "liabilities": 26884735,
    "commonstockvalue": 22941,
    "additionalpaidincapitalcommonstock": 32044335,
    "retainedearningsaccumulateddeficit": -23844671,
    "accumulatedothercomprehensiveincomelossnetoftax": 135567,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 8358172,
    "liabilitiesandstockholdersequity": 35242907,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 420000000,
    "commonstocksharesissued": 22941157,
    "commonstocksharesoutstanding": 22941157,
    "researchanddevelopmentexpense": 1554603,
    "generalandadministrativeexpense": 3032138,
    "operatingexpenses": 4586741,
    "operatingincomeloss": -4586741,
    "interestincomeexpensenet": -2007687,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -6594428,
    "incometaxexpensebenefit": -335832,
    "netincomeloss": -6258596,
    "translationadjustmentfunctionaltoreportingcurrencyincreasedecreasegrossoftax": 472559,
    "comprehensiveincomenetoftax": -5786037,
    "earningspersharebasicanddiluted": -0.28,
    "weightedaveragenumberofsharesoutstandingbasic": 22283377,
    "sharesissued": 22941157,
    "stockholdersequity": 135567,
    "stockissuedduringperiodsharesnewissues": 408718,
    "stockissuedduringperiodvaluenewissues": 4250676,
    "exerciseofwarrantsshares": 38683,
    "exerciseofwarrantsamount": 400465,
    "restrictedsharesissuedasstockbasedcompensationshares": 56702,
    "restrictedsharesissuedasstockbasedcompensationamount": 263114,
    "othercomprehensiveincomeforeigncurrencytranslationgainlossarisingduringperiodtax": 472559,
    "issuanceofcommonsharesnetofcosts": 957193,
    "profitloss": -6258596,
    "depreciationdepletionandamortization": 98075,
    "accretionexpense": 2007687,
    "sharebasedcompensation": 50000,
    "increasedecreaseinprepaidexpense": 767050,
    "increasedecreaseininventories": 564313,
    "increasedecreaseinaccountspayable": -39914,
    "increasedecreaseinduetorelatedparties": -681298,
    "increasedecreaseinotheraccruedliabilities": 94141,
    "netcashprovidedbyusedinoperatingactivities": -5998097,
    "paymentstoacquireintangibleassets": 81952,
    "paymentstoacquirepropertyplantandequipment": 90730,
    "paymentstodevelopsoftware": 663758,
    "netcashprovidedbyusedininvestingactivities": -836440,
    "proceedsfromissuanceofcommonstock": 15750672,
    "costsincurredinrelationtoequityfinancing": 957193,
    "proceedsfromwarrantexercises": 400503,
    "proceedsfromnotespayable": 25000000,
    "paymentsoffinancingcosts": 1525035,
    "repaymentsofnotespayable": 600000,
    "repaymentsofinsurancefinancing": 82555,
    "netcashprovidedbyusedinfinancingactivities": 37986392,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 31151855,
    "foreigncurrencytransactiongainlossrealized": 607409,
    "prepaymentofequitycompensation": 50000,
    "licensesacquiredthroughstockissuance": 100000,
    "monitoringfeesaddedtonotespayable": 718661,
    "cash": 31865371,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.21,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9710,
    "employeeservicesharebasedcompensationtaxbenefitfromcompensationexpense": 12100,
    "advanceroyalties": 1380000,
    "deferredrevenue": 103000,
    "propertyplantandequipmentgross": 346500,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 144355,
    "depreciation": 69000,
    "finitelivedpatentsgross": 516935,
    "finitelivedintangibleassetsaccumulatedamortization": 125437,
    "finitelivedintangibleassetsgross": 391498,
    "capitalizedcomputersoftwarenet": 663758,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 37139,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 54930,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 53826,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 53770,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 52427,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 139406,
    "amortizationofintangibleassets": 29000,
    "prepaidexpensecurrent": 592695,
    "otherinventory": 587493,
    "prepaidtaxes": 89325,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 5733370,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 19188724,
    "longtermdebt": 24922094,
    "relatedpartytransactionduefromtorelatedparty": 148795,
    "amountinvoicedbypharmatoddlandtcl": 2441108,
    "amountsinvoicedbyddltopharma": -17213,
    "amountsrepaidbyddltopharma": -3209084,
    "foreigncurrencytranslationrelatedparty": 103891,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -5030204,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -1564224,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1384830,
    "incometaxreconciliationforeignincometaxratedifferential": 100604,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 5561000,
    "incometaxreconciliationotheradjustments": 20226,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1523861,
    "rdcreditreceived": 335832,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.19,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.02,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.04,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.23,
    "incometaxreconciliationrdcreditreceived": 0.05,
    "effectiveincometaxratecontinuingoperations": 0.05,
    "deferredtaxassetsoperatinglosscarryforwards": 5204000,
    "researchanddevelopmentenhancement": 1057000,
    "otheritems": -333000,
    "deferredtaxassetsvaluationallowance": 5928000,
    "operatinglosscarryforwards": 7096000,
    "deferredincometaxesandtaxcredits": 614362,
    "incometaxreconciliationtaxcreditsother": 335832,
    "stockholdersequityreversestocksplit": "one (1) for ten (10) basis",
    "relatedpartycosts": 127520,
    "proceedsfromissuanceofwarrants": 6000,
    "warrantsexercised": 750,
    "classofwarrantorrightoutstanding": 792353,
    "stockcompensationexpensepaid": 59000
  },
  {
    "date": "2020-03-30",
    "symbol": "NMRD",
    "period": "FY",
    "entityregistrantname": "Nemaura Medical Inc.",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-03-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1602078,
    "currentfiscalyearenddate": "--03-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "001-38355",
    "entityincorporationstatecountrycode": "NV",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "cashandcashequivalentsatcarryingvalue": 106107,
    "prepaidexpenseandotherassets": 452463,
    "inventorynet": 286309,
    "assetscurrent": 844879,
    "propertyplantandequipmentnet": 162064,
    "finitelivedintangibleassetsnet": 213080,
    "otherassetsnoncurrent": 375144,
    "assets": 1220023,
    "accountspayablecurrent": 293608,
    "duetorelatedpartiescurrent": 830093,
    "otherliabilitiescurrent": 168966,
    "deferredrevenuecurrent": 93022,
    "liabilitiescurrent": 1385689,
    "deferredrevenueandcreditsnoncurrent": 1147278,
    "liabilities": 2532967,
    "commonstockvalue": 20851,
    "additionalpaidincapitalcommonstock": 16589272,
    "retainedearningsaccumulateddeficit": -17586075,
    "accumulatedothercomprehensiveincomelossnetoftax": -336992,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -1312944,
    "liabilitiesandstockholdersequity": 1220023,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 200000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 420000000,
    "commonstocksharesissued": 20850848,
    "commonstocksharesoutstanding": 20850848,
    "researchanddevelopmentexpense": 2009323,
    "generalandadministrativeexpense": 2769161,
    "operatingexpenses": 4778484,
    "operatingincomeloss": -4778484,
    "interestincomeoperating": 3926,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -4774558,
    "incometaxexpensebenefit": -614362,
    "netincomeloss": -4160196,
    "translationadjustmentfunctionaltoreportingcurrencyincreasedecreasegrossoftax": 2896,
    "comprehensiveincomenetoftax": -4157300,
    "earningspersharebasicanddiluted": -0.2,
    "weightedaveragenumberofsharesoutstandingbasic": 20806307,
    "sharesissued": 20850848,
    "stockholdersequity": -336992,
    "exerciseofwarrantsshares": 2500,
    "exerciseofwarrantsamount": 25997,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcostsshares": 14338,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcostsamount": 112113,
    "stockissuedduringperiodsharesreversestocksplits": 418,
    "restrictedsharesissuedasstockbasedcompensationshares": 68000,
    "restrictedsharesissuedasstockbasedcompensationamount": 479257,
    "othercomprehensiveincomeforeigncurrencytranslationgainlossarisingduringperiodtax": 2896,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcosts": 40365,
    "profitloss": -4160196,
    "depreciationdepletionandamortization": 54840,
    "gainlossonsaleofpropertyplantequipment": -12978,
    "sharebasedcompensation": 98150,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -186281,
    "increasedecreaseinaccruedinterestreceivablenet": 258523,
    "increasedecreaseinaccountspayable": 138485,
    "increasedecreaseinduetorelatedparties": -91347,
    "increasedecreaseinotheraccruedliabilities": 102898,
    "netcashprovidedbyusedinoperatingactivities": -3449545,
    "paymentstoacquireintangibleassets": 53206,
    "paymentstoacquirepropertyplantandequipment": 157825,
    "netcashprovidedbyusedininvestingactivities": -211031,
    "costsincurredinrelationtoatmfinancing": 40365,
    "proceedsfromissuanceofcommonstock": 152492,
    "proceedsfromwarrantexercises": 26000,
    "repaymentsofnotespayable": 40896,
    "netcashprovidedbyusedinfinancingactivities": 97231,
    "cashandcashequivalentsperiodincreasedecrease": -3563345,
    "foreigncurrencytransactiongainlossrealized": -71212,
    "prepaymentofequitycompensation": 27400,
    "amountofinsurancefundedthroughnotepayable": 123491,
    "cash": 106107,
    "seniorcreditfacilityavailable": 8000000,
    "lineofcreditfacilityremainingborrowingcapacity": 3500000,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.21,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9710,
    "advanceroyalties": 1240000,
    "deferredrevenue": 93000,
    "propertyplantandequipmentgross": 226548,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 64484,
    "depreciation": 46000,
    "finitelivedintangibleassetsgross": 307009,
    "finitelivedintangibleassetsaccumulatedamortization": 93929,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 19000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 19000,
    "amortizationofintangibleassets": 19000,
    "prepaidexpensecurrent": 27400,
    "prepaidtaxes": 100708,
    "accruedliabilitiescurrent": 86411,
    "accruedinsurancecurrent": 82555,
    "otheraccountspayableandaccruedliabilities": 168966,
    "relatedpartytransactionduefromtorelatedparty": 830093,
    "amountinvoicedbypharmatoddlandtcl": 1800517,
    "amountsinvoicedbyddltopharma": -10963,
    "amountsrepaidbyddltopharma": -1897222,
    "foreigncurrencytranslationrelatedparty": -26918,
    "lineofcreditfacilityinterestrateduringperiod": 0.08,
    "lineofcreditfacilityexpirationperiod": "P5Y",
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -2470107,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -2304451,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1003000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 4193000,
    "incometaxreconciliationotheradjustments": 125000,
    "changeinrateallowance": 119000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 990000,
    "rdcreditreceived": 614362,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.19,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.05,
    "effectiveincometaxratereconciliationotheradjustments": 0.02,
    "incometaxreconciliationchangeinrateallowance": 0.02,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.21,
    "incometaxreconciliationrdcreditreceived": 0.13,
    "effectiveincometaxratecontinuingoperations": 0.13,
    "deferredtaxassetsoperatinglosscarryforwards": 3926000,
    "researchanddevelopmentenhancement": 797000,
    "otheritems": -319000,
    "deferredtaxassetsvaluationallowance": 4404000,
    "operatinglosscarryforwards": 5532000,
    "deferredincometaxesandtaxcredits": 614362,
    "stockholdersequityreversestocksplit": "one (1) for ten (10) basis",
    "stockissuedduringperiodsharesnewissues": 14338,
    "stockissuedduringperiodvaluenewissues": 152492,
    "saleofremainingcommonstock": 19392401,
    "relatedpartycosts": 40365,
    "proceedsfromissuanceofwarrants": 63811,
    "warrantsexercised": 6136,
    "classofwarrantorrightoutstanding": 185570,
    "relatedpartytaxexpenseduetoaffiliatescurrent": 451924,
    "cashexpenses": 186176,
    "equityinstruments": 297500,
    "repaymentsofdebt": 123451,
    "debtinstrumentinterestrateeffectivepercentage": 0.0528,
    "otheraccruedliabilitiescurrent": 82555
  },
  {
    "date": "2019-03-30",
    "symbol": "NMRD",
    "period": "FY",
    "entityregistrantname": "Nemaura Medical Inc.",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-03-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1602078,
    "currentfiscalyearenddate": "--03-31",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "cashandcashequivalentsatcarryingvalue": 3740664,
    "prepaidexpenseandotherassets": 736460,
    "inventorynet": 38036,
    "assetscurrent": 4515160,
    "propertyplantandequipmentnet": 56871,
    "finitelivedintangibleassetsnet": 191684,
    "otherassetsnoncurrent": 248555,
    "assets": 4763715,
    "accountspayablecurrent": 161348,
    "duetorelatedpartiescurrent": 964679,
    "otherliabilitiescurrent": 107759,
    "deferredrevenuecurrent": 65175,
    "liabilitiescurrent": 1298961,
    "deferredrevenueandcreditsnoncurrent": 1237850,
    "liabilities": 2536811,
    "commonstockvalue": 207656,
    "additionalpaidincapitalcommonstock": 15785015,
    "retainedearningsaccumulateddeficit": -13425879,
    "accumulatedothercomprehensiveincomelossnetoftax": -339888,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 2226904,
    "liabilitiesandstockholdersequity": 4763715,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 200000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 420000000,
    "commonstocksharesissued": 207655916,
    "commonstocksharesoutstanding": 207655916,
    "researchanddevelopmentexpense": 2312412,
    "generalandadministrativeexpense": 2180056,
    "operatingexpenses": 4476724,
    "operatingincomeloss": -4476724,
    "interestincomeoperating": 23927,
    "netincomeloss": -4452797,
    "translationadjustmentfunctionaltoreportingcurrencyincreasedecreasegrossoftax": -299263,
    "comprehensiveincomenetoftax": -4752060,
    "earningspersharebasicanddiluted": -0.02,
    "weightedaveragenumberofsharesoutstandingbasic": 180903839,
    "sharesissued": 207655916,
    "stockholdersequity": -339888,
    "conversionofpreferredstockintocommonstockshares": 137324000,
    "conversionofpreferredstockintocommonstockamount": -137187,
    "issuanceofstockexerciseofinvictuswarrantsshares": 50000,
    "issuanceofstockexerciseofinvictuswarrantsamount": 450,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcostsshares": 234998,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcostsamount": 293768,
    "issuanceofcommonsharesandwarrantsunderpublicofferingnetofofferingcostsshares": 1942061,
    "issuanceofcommonsharesandwarrantsunderpublicofferingnetofofferingcostsamount": 1689499,
    "exerciseofwarrantsunderpublicofferingshares": 61357,
    "exerciseofwarrantsunderpublicofferingamount": 63750,
    "underwriterpurchaseofoptiontopurchaseunits": 100,
    "stockissuedduringperiodsharessharebasedcompensation": 367500,
    "stockissuedduringperiodvaluesharebasedcompensation": 514957,
    "othercomprehensiveincomelossnetoftax": -299263,
    "forgivenessofpayablebyrelatedparty": 302819,
    "issuanceofcommonsharesunderatmfinancingnetofofferingcosts": 161102,
    "issuanceofcommonsharesandwarrantsunderpublicofferingnetofofferingcosts": 328302,
    "profitloss": -4452797,
    "depreciationdepletionandamortization": 33407,
    "sharebasedcompensation": 429610,
    "othernoncashincomeexpense": 34796,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 456125,
    "increasedecreaseinaccruedinterestreceivablenet": 70759,
    "increasedecreaseininventories": -37396,
    "increasedecreaseinaccountspayable": 98118,
    "increasedecreaseinduetorelatedparties": 697182,
    "increasedecreaseinotheraccruedliabilities": 21494,
    "netcashprovidedbyusedinoperatingactivities": -3560952,
    "paymentstoacquireintangibleassets": 20331,
    "paymentstoacquirepropertyplantandequipment": 59666,
    "fixedratesavingsaccount": -4483852,
    "netcashprovidedbyusedininvestingactivities": 4403855,
    "costsincurredinrelationtoatmfinancing": 161102,
    "costsincurredinrelationtopublicoffering": 328302,
    "proceedsfromissuanceofcommonstock": 455105,
    "proceedsfromissuanceinitialpublicoffering": 2019743,
    "proceedsfromwarrantexercises": 64311,
    "proceedsfromrepurchaseofequity": 100,
    "netcashprovidedbyusedinfinancingactivities": 2049855,
    "cashandcashequivalentsperiodincreasedecrease": 2892758,
    "foreigncurrencytransactiongainlossrealized": 25571,
    "conversionofseriespreferredstocktocommonstock": 137324,
    "prepaymentofequitycompensation": 85715,
    "forgivenessofpayablefromrelatedparty": 302819,
    "cash": 3740664,
    "foreigncurrencyexchangeratetranslation": 1.3026,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 97103,
    "advanceroyalties": 1303000,
    "deferredrevenue": 65000,
    "propertyplantandequipmentgross": 77597,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 20726,
    "depreciation": 9000,
    "finitelivedintangibleassetsgross": 261938,
    "finitelivedintangibleassetsaccumulatedamortization": 70254,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 19000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 19000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 19000,
    "relatedpartytransactionduefromtorelatedparty": 964679,
    "amountinvoicedbypharmatoddlandtcl": 2312412,
    "amountsinvoicedbyddltopharma": -977,
    "amountsrepaidbyddltopharma": -1569496,
    "amountsinvoicedbybwtoddl": 2206,
    "amountsrepaidbyddltobw": -5622,
    "foreigncurrencytranslationrelatedparty": -84843,
    "forgivenessofpayableaccountedforasequitycontribution": -302819,
    "professionalfees": 2160,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -2726862,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -1725935,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -4452797,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -935000,
    "incometaxreconciliationforeignincometaxratedifferential": 55000,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 297000,
    "incometaxreconciliationotheradjustments": 1000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1176000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.19,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.01,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.07,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.26,
    "deferredtaxassetsoperatinglosscarryforwards": 2641000,
    "researchanddevelopmentenhancement": 867000,
    "otheritems": -103000,
    "deferredtaxassetsvaluationallowance": 3405000,
    "operatinglosscarryforwards": 11500000,
    "usfederalcorporateincometaxblendedrate": 0.3079,
    "warrantsvested": 50000
  }
]